EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of an Amplicon Nanopore Sequencing Strategy for Detection of Mutations Conferring Intermediate Resistance to Vancomycin in Staphylococcus aureus Strains

Abraham G Moller iD, Robert A Petit, Michelle H Davis, Timothy D Read iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.02728-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Abraham G Moller und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Bacteremia, Nanopore Sequencing, Staphylococcal Infections, Vancomycin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Science Foundation, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteremia mortality is known to increase rapidly with time after infection, making rapid diagnostics and treatment necessary. Successful treatment depends on correct administration of antibiotics based on knowledge of strain antibiotic susceptibility. Staphylococcus aureus is a major causative agent of bacteremia that is also commonly antibiotic resistant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaNanopore SequencingStaphylococcal InfectionsVancomycin-Resistant Staphylococcus aureusHumansAnti-Bacterial AgentsMicrobial Sensitivity TestsMutationStaphylococcus aureusVancomycin

Stichwörter der Autor:innen

Staphylococcus aureusamplicon sequencingantibiotic resistanceclinical microbiologydiagnosticsgenomicsnanopore sequencingvancomycin resistancevancomycin-intermediate Staphylococcus aureus

Substanzen

Anti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia, USA.
  • Microbiology and Molecular Genetics (MMG), Graduate Division of Biological and Biomedical Sciences (GDBBS), Emory University, Atlanta, Georgia, USA.
  • Theiagen Genomics, Highlands Ranch, Colorado, USA.

ORCID-Profile: Abraham G Moller, Timothy D Read

Förderung

  • NIAID NIH HHS
  • National Science Foundation
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Moller, A. G., Petit, R. A., Davis, M. H., & Read, T. D. (2023). Development of an Amplicon Nanopore Sequencing Strategy for Detection of Mutations Conferring Intermediate Resistance to Vancomycin in Staphylococcus aureus Strains. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02728-22

Vancouver

Moller AG, Petit RA, Davis MH, Read TD. Development of an Amplicon Nanopore Sequencing Strategy for Detection of Mutations Conferring Intermediate Resistance to Vancomycin in Staphylococcus aureus Strains. Microbiology Spectrum. 2023. doi:10.1128/spectrum.02728-22

BibTeX
@article{Moller2023,
  author = {Moller, Abraham G and Petit, Robert A and Davis, Michelle H and Read, Timothy D},
  title = {Development of an Amplicon Nanopore Sequencing Strategy for Detection of Mutations Conferring Intermediate Resistance to Vancomycin in Staphylococcus aureus Strains},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.02728-22}
}
Kostenlos starten →